Authors
Latest:
EmPATHy: More Empathy Toward Patients Improves Outcomes in Their HealthBy empathizing with patients and creating an environment where patients feel comfortable and open to sharing, pharmacists can increase compliance and adherence.
Latest:
Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy SettingsAlthough pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.
Latest:
Pediatric Weight is Crucial to Perfecting the DoseEvidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.
Latest:
AAN 2025: Insights on Pediatric Multiple Sclerosis Treatment and ManagementLauren B. Krupp, MD, FAAN, provides comprehensive guidance on treating pediatric multiple sclerosis, emphasizing early intervention, high-efficacy therapies, and holistic family support.
Latest:
Pharmacists Can Tackle Thimerosal Misinformation Through Education, Empathy, and TransparencyAdam James, PharmD, and Chris Altman, PharmD, explain how pharmacists can build trust and reduce vaccine hesitancy by clearly communicating thimerosal’s limited role in today’s immunizations and addressing patient concerns with empathy and education.
Latest:
Future Considerations for the Management of HyperlipidemiaPanelists discuss how anticipated updates to cholesterol guidelines and related cardiovascular-kidney-metabolic health (CKM) guidelines this year are expected to shape low-density lipoprotein cholesterol (LDL-C) management strategies and influence treatment recommendations for high-risk patients.
Latest:
AI Can Help Bridge Disparities in Cancer Care Through Digital PlatformsCollaboration between AI-based platforms and health care organizations offers promising results.
Latest:
Interactive Case Studies: September 2023Cases highlight an acute subdural hematoma and chronic obstructive pulmonary disease.
Latest:
AI at the Counter: How Artificial Intelligence Is Shaping the Future of Pharmacy PracticeAI transforms pharmacy practice by streamlining workflows and enhancing patient care, while pharmacists adapt to new roles and challenges in health care.
Latest:
Zongertinib: A Promising New TKI for HER2-Mutated NSCLCIf approved, zongertinib may be a new first-line oral tyrosine kinase inhibitor (TKI) for patients with HER2-mutated non-small cell lung cancer (NSCLC), a transformative step in TKI drug development.
Latest:
Pharmacogenomics Offers a Glimpse Into the Future of PharmacyOne day soon, including pharmacogenomics testing for all patients will be essential for precise prescribing.
Latest:
Evaluation of Antibiotic Administration Surrounding Interventional Radiology ProceduresImplementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.
Latest:
Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine CarcinomasDLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation.
Latest:
Understanding the Role of Oncology Pharmacists in Academic vs Community Cancer CentersTheir expertise complements multidisciplinary teams in a variety of clinical settings.
Latest:
Staff Pharmacists Discuss Updated Carboplatin Drug Shortage Mitigation Strategies at the University of Illinois at Chicago Oncology Clinic PharmacyAfter carboplatin joined the growing list of drug shortages, staff pharmacists acted to minimize the impact on patients.
Latest:
Clinical Overview: Mavacamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMavacamten is a first-in-class selective allosteric modulator of beta cardiac myosin ATPase for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.
Latest:
Therapies in the Pipeline for Prostate CancerNew potential medications may continue to expand the role of targeted agents.
Latest:
Tip of the Week: We Are All Clinician-ManagersThe evolution of health care to a more patient-centric focus suggests an even greater marriage between the concepts of manager and clinician.
Latest:
Microbiology Quality Control Helps the Cell and Gene Therapy Segment Cure the IncurableWith the continued advancement and approval of cell and gene therapies, the need for trustworthy microbiology quality control solutions is at an all-time high.
Latest:
How Can Pharmacies Close the Gap on Vaccine Uptake?Pharmacists and the pharmacies they support are in a strong position to increase vaccination rates and address any questions related to vaccine hesitancy.
Latest:
Critical Success Factors for Commercializing Specialty Drugs, Cell and Gene TherapiesAlthough payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.”
Latest:
Once-Daily Oral Pill for Plaque Psoriasis Shows PromiseDeuvacracitinib (Sotyktu), which the FDA approved in September 2022, is a first-of-its-class tyrosine kinase 2 inhibitor and a member of the Janus kinase family.
Latest:
Case Study: Review of ACE Inhibitor-Induced Bowel AngioedemaGlobally, more than 40 million patients are currently taking an ACE inhibitor, primarily for the treatment of high blood pressure and heart failure.
Latest:
Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid LeukemiaThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Introducing Tarlatamab-dlle: A New Era in Oncology TreatmentThe therapy offers new hope in solid tumor treatment with fewer adverse effects.
Latest:
During Summer Months, Counsel Patients on Preventing Lyme DiseaseEducation about prevention measures and early signs and symptoms of the condition are crucial
Latest:
Cancer Vaccine Trials With Canines May Benefit Cancer Prevention in HumansThe clinical trial success in canines may have broader implications for applicability.
